These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6599950)

  • 41. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE; Gillilan R; Watson WA
    J Toxicol Clin Toxicol; 1992; 30(4):549-56. PubMed ID: 1433426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastric decontamination--a view for the millennium.
    Bateman DN
    J Accid Emerg Med; 1999 Mar; 16(2):84-6. PubMed ID: 10191436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Successful therapy of salicylate poisoning using glycine and activated charcoal].
    Mühlebach S; Steger P; Conen D; Wyss PA
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2127-9. PubMed ID: 8999500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does emergency medical services transport for pediatric ingestion decrease time to activated charcoal?
    Tuuri RE; Ryan LM; He J; McCarter RJ; Wright JL
    Prehosp Emerg Care; 2009; 13(3):295-303. PubMed ID: 19499464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of acute poisoning caused by carbamazepine, digoxin, and acetylsalicylic acid, with repeated doses of activated charcoal].
    Montoya-Cabrera MA; Escalante-Galindo P; Sauceda-García JM; Márquez-Enríquez LM; González-Cabello H; Flores-Alvarez E
    Gac Med Mex; 1995; 131(3):349-54. PubMed ID: 8582575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-poisoning with aspirin and five other drugs.
    JAMA; 1970 Nov; 214(9):1710-1. PubMed ID: 5536544
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of Activated Charcoal on Rivaroxaban Complex Absorption.
    Ollier E; Hodin S; Lanoiselée J; Escal J; Accassat S; De Magalhaes E; Basset T; Bertoletti L; Mismetti P; Delavenne X
    Clin Pharmacokinet; 2017 Jul; 56(7):793-801. PubMed ID: 27910037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose.
    Tenenbein M; Cohen S; Sitar DS
    Ann Emerg Med; 1987 Aug; 16(8):838-41. PubMed ID: 2887134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed absorption following enteric-coated aspirin overdose.
    Wortzman DJ; Grunfeld A
    Ann Emerg Med; 1987 Apr; 16(4):434-6. PubMed ID: 3826813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose.
    Dargan PI; Wallace CI; Jones AL
    Emerg Med J; 2002 May; 19(3):206-9. PubMed ID: 11971828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of activated charcoal hemoperfusion in removing lethal doses of barbiturates and salicylate from the blood of rats and dogs.
    Hill JB; Palaia FL; McAdams JL; Palmer PJ; Maret SM
    Clin Chem; 1976 Jun; 22(6):754-60. PubMed ID: 1277456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 54. [Gastric lavage and activated charcoal in acute poisonings].
    Rygnestad T; Nordmo E; Jacobsen D
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2010-1. PubMed ID: 11008537
    [No Abstract]   [Full Text] [Related]  

  • 55. In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose.
    Chung DC; Murphy JE; Taylor TW
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):219-24. PubMed ID: 7109011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro phosphate-binding ability of calcium-based agents is augmented by co-administration of activated charcoal.
    Jia M; Cheng XY; Zuo L
    Clin Nephrol; 2013 Jun; 79(6):471-6. PubMed ID: 23253906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis.
    Kato S; Suzuki K; Ukawa H; Komoike Y; Takeuchi K
    Dig Dis Sci; 2001 Aug; 46(8):1690-9. PubMed ID: 11508669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective evaluation of gastric emptying in the self-poisoned patient.
    Merigian KS; Woodard M; Hedges JR; Roberts JR; Stuebing R; Rashkin MC
    Am J Emerg Med; 1990 Nov; 8(6):479-83. PubMed ID: 1977400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.